This story was originally published on March 25, 2020. As part of MedPage Today s review of top stories in 2020, we are republishing it, along with an update on the COVID-19 pandemic s impact on cancer care within the Seattle Cancer Care Alliance, reviewing subsequent developments since.
While having an unprecedented impact on all aspects of the nation s healthcare system, the COVID-19 pandemic created unique circumstances and challenges for cancer care, according to authors of a review from the early U.S. epicenter in metropolitan Seattle.
The first confirmed U.S. case of COVID-19 was reported on Jan. 20 in Snohomish County, about an hour north of Seattle. The first COVID-19 death in the country occurred there, as well.
Share this article
PLYMOUTH MEETING, Pa., Jan. 13, 2021 /PRNewswire/ New research in the January 2021 issue of
JNCCN Journal of the National Comprehensive Cancer Network finds more than a third of eligible people miss timely screening tests for colorectal cancer and at least a quarter appear to miss timely screening tests for breast and cervical cancers. The study comes from the University of Alberta, Faculty of Medicine and Dentistry in Alberta, Canada, with findings based on self-reported results from the Canadian Community Health Survey (CCHS) from 2007-2016. According to the author, the results also point to evidence of screening disparities being linked to lower socioeconomic status and identifiable minority race echoing a similar study conducted in the United States by the Centers for Disease Control.